Much like an exhibition that highlights an artist’s oeuvre, our October anniversary issue was designed to be a 20-year retrospective on the pharma industry, through the lens of Pharma Manufacturing magazine. Inside, you will find that we have revisited all the topics explored in our inaugural issue, from CGMPs to 21 CFR Part 11 to continuous manufacturing, analyzing the industry’s great works — and its shortcomings. We have sought out the industry’s foremost experts in these areas for commentary, and in some cases, the original authors have returned.
For the past six years, I have overseen the content on the Pharma Manufacturing brand. As chief content director, I have made it my mission to deliver our brand’s mission: To provide professionals the tools they need to deliver authentic innovation in today’s pharma environment, presented in a way that is straightforward and unpretentious, in a style that is refreshing and unique.
I believe that editorial is a living, breathing part of our brand and cannot stagnate. B2B publishing does not have to be boring, and as a journalist in this space I have been relentless in my pursuit to bring you high quality, readable content. Reporting on one of the most innovative industries in the world — one that has saved millions of lives — has been and continues to be a great privilege. It is my sincere hope that we have been successful and that you truly enjoy the content our brand produces.
In the words written two decades ago by our very first editorial director, Keith Larson, who has returned to the pages of Pharma Manufacturing to deliver this month’s ‘From the editor’ column: “This is your magazine and we want it to meet your needs.”
